Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 NDC API

1 NDC API

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

DIGITAL CONTENT

12 NEWS #PharmaBuzz

media
12 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

14DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ostarine, 841205-47-8, Gtx-024, Mk-2866, Enobosarm [usan], Mk-2866 (gtx-024)

Molecular Formula

C₁₉H₁₄F₃N₃O₃

Molecular Weight

389.3 g/mol

InChI Key

JNGVJMBLXIUVRD-SFHVURJKSA-N

FDA UNII

O3571H3R8N

Enobosarm is a non-steroidal agent with anabolic activity. Selective androgen receptor modulator (SARM) GTx-024 is designed to work like testosterone, thus promoting and/or maintaining libido, fertility, prostate growth, and muscle growth and strength. Mimicking testosterone's action, this agent may increase lean body mass, thereby ameliorating muscle wasting in the hypermetabolic state of cancer cachexia.

1 2D Structure

Enobosarm

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

2.1.2 InChI

InChI=1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1

2.1.3 InChI Key

JNGVJMBLXIUVRD-SFHVURJKSA-N

2.1.4 Canonical SMILES

CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O

2.1.5 Isomeric SMILES

C[C@](COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O

2.2 Other Identifiers

2.2.1 UNII

O3571H3R8N

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (2s)-3-(4-cyanophenoxy)-n-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide

2. Gtx 024

3. Gtx-024

4. Mk 2866

5. Mk-2866

6. Mk2866

7. Ostarine

2.3.2 Depositor-Supplied Synonyms

1. Ostarine

2. 841205-47-8

3. Gtx-024

4. Mk-2866

5. Enobosarm [usan]

6. Mk-2866 (gtx-024)

7. 1202044-20-9

8. Ostarine (mk2866)

9. Ostarine(mk-2866)

10. (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

11. (s)-n-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide

12. Mk 2866

13. O3571h3r8n

14. Enobosarm (usan)

15. Propanamide, 3-(4-cyanophenoxy)-n-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-, (2s)-

16. Mk2866

17. ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide)

18. Enobosarm [usan:inn]

19. Gtx 024

20. Unii-o3571h3r8n

21. Ostarine-d4

22. (s)-ostarine

23. (2s)-3-(4-cyanophenoxy)-n-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide

24. Enobosarm [inn]

25. Ostarine(mk-2286)

26. Enobosarm [who-dd]

27. Mls006010739

28. Sarm S-22

29. Schembl109069

30. Not For Sale-patented"

31. Chembl1738889

32. Dtxsid30233006

33. Ex-a638

34. Hms3654e16

35. Amy38131

36. Bcp02391

37. Bcp28483

38. Bdbm50529668

39. S1174

40. Zinc35793636

41. Akos005266718

42. Ccg-268514

43. Cs-0562

44. Db12078

45. Ex-8408

46. Sb16683

47. Ncgc00346499-01

48. Ac-30221

49. Hy-13273

50. Smr004701698

51. Sw219159-1

52. Ostarine(mk2286); 1202044-20-9

53. D10221

54. H12015

55. A864177

56. Q5379258

57. 1235370-13-4

58. Mk-2866(d4);mk2866(d4);gtx-024(d4);gtx024;(s)-n-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide-d4

59. Mk-2866; Gtx024;((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide)

60. Propanamide, 3-?(4-?cyanophenoxy)?-?n-?[4-?cyano-?3-?(trifluoromethyl)?phenyl]?-?2-?hydroxy-?2-?methyl-?, (2s)?-

61. Rlj

2.4 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₁₄F₃N₃O₃
Molecular Weight	389.3 g/mol
XLogP3	2.7
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	5
Exact Mass	389.09872580 g/mol
Monoisotopic Mass	389.09872580 g/mol
Topological Polar Surface Area	106 Å²
Heavy Atom Count	28
Formal Charge	0
Complexity	658
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1